More on JSPR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-546.7% Growth)
- Ratings (7.3 Score)

Upcoming Events

- Earnings (11/10/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Jasper Therapeutics (NQ:JSPR)
Delayed: 1.38 +0.01 (0.73%)
Prev. Close $1.37  
Open$1.36 
52 Wk High$ 
52 Wk Low$ 
Day High$1.44 
Day Low$1.35 
P/E N/A  
EPS$ 
Volume1,174,074 

Friends, Peers and Foes (?): HUM, UNCY VSTS (more...)

Feb 25, 2026 04:48 PM Form SCHEDULE 13G Jasper Therapeutics, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Feb 24, 2026 04:30 PM Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
Feb 18, 2026 05:29 PM Form SCHEDULE 13D/A Jasper Therapeutics, Filed by: Carlyle Group Inc.
Feb 12, 2026 10:33 AM Form SCHEDULE 13G Jasper Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Feb 11, 2026 01:39 PM Form SCHEDULE 13G Jasper Therapeutics, Filed by: MORGAN STANLEY
Feb 10, 2026 04:01 PM Form 4 Jasper Therapeutics, For: Feb 06 Filed by: Mahal Jeetinder Singh
Jan 26, 2026 03:29 PM Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
Jan 13, 2026 07:18 AM Rodman & Renshaw Starts Jasper Therapeutics (JSPR) at Buy
Jan 9, 2026 04:33 AM Jasper Therapeutics (JSPR) Reiterated at Market Outperform by Citizens
Jan 8, 2026 07:08 AM Form 8-K Jasper Therapeutics, For: Jan 08
View All Articles

Entities mentioned with JSPR

View All Entities